JPRN-jRCT2080225082已完成3 期
A phase III, randomized, double masked, placebo controlled, parallel, multicenter study: To evaluate efficacy and safety of 3 % DE-089C ophthalmic solution in subject with Dry eye.
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 300
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 ot applicable（—）
- 性别
- All
入选标准
- •Outpatients
- •- Both eyes diagnosed as having dry eye
排除标准
- •- Ocular condition which affects ocular surface expect dry eye
- •- Ocular disease which needs treatment expect dry eye
- •- Eyelid closure failure (e.g. blepharospasm, lagophthalmos)
- •- Anyone otherwise considered unsuitable for the study by the investigators
研究者
相似试验
进行中（未招募）
1 期
A large scale study to confirm and expand the information on the safety and effectiveness of atropine in treating the progression of myopia in pediatric subjects.myopiaEUCTR2020-003976-42-NLOcumension (Hong Kong) Limited678
进行中（未招募）
1 期
A large scale study to confirm and expand the information on the safety and effectiveness of atropine in treating the progression of myopia in pediatric subjects.MedDRA version: 20.0Level: PTClassification code 10028651Term: MyopiaSystem Organ Class: 10015919 - Eye disordersmyopiaMedDRA version: 20.0Level: PTClassification code 10069153Term: Congenital myopiaSystem Organ Class: 10010331 - Congenital, familial and genetic disordersMedDRA version: 20.0Level: PTClassification code 10073286Term: Pathologic myopiaSystem Organ Class: 10015919 - Eye disordersMedDRA version: 20.0Level: PTClassification code 10075919Term: PseudomyopiaSystem Organ Class: 10015919 - Eye disordersMedDRA version: 20.0Level: PTClassification code 10078300Term: Acute myopiaSystem Organ Class: 10015919 - Eye disordersMedDRA version: 20.0Level: PTClassification code 10079195Term: Myopia correctionSystem Organ Class: 10042613 - Surgical and medical proceduresEUCTR2020-003976-42-SKOcumension (Hong Kong) Limited678
进行中（未招募）
1 期
A large scale study to confirm and expand the information on the safety and effectiveness of atropine in treating the progression of myopia in pediatric subjects.MedDRA version: 20.1Level: LLTClassification code 10051455Term: Malignant myopiaSystem Organ Class: 10015919 - Eye disordersMedDRA version: 20.0Level: LLTClassification code 10073288Term: Degenerative myopiaSystem Organ Class: 10015919 - Eye disordersMedDRA version: 20.0Level: LLTClassification code 10036803Term: Progressive high (degenerative) myopiaSystem Organ Class: 10015919 - Eye disordersMedDRA version: 20.0Level: PTClassification code 10078300Term: Acute myopiaSystem Organ Class: 10015919 - Eye disordersMedDRA version: 20.0Level: PTClassification code 10069153Term: Congenital myopiaSystem Organ Class: 10010331 - Congenital, familial and genetic disordersMedDRA version: 20.0Level: PTClassification code 10073286Term: Pathologic myopiaSystem Organ Class: 10015919 - Eye disordersmyopiaEUCTR2020-003976-42-HUOcumension (Hong Kong) Limited678
进行中（未招募）
1 期
A large scale study to confirm and expand the information on the safety and effectiveness of atropine in treating the progression of myopia in pediatric subjects.myopiaEUCTR2020-003976-42-ESOcumension (Hong Kong) Limited678
进行中（未招募）
1 期
A large scale study to confirm and expand the information on the safety and effectiveness of atropine in treating the progression of myopia in pediatric subjects.myopiaEUCTR2020-003976-42-IEOcumension (Hong Kong) Limited678